Template:Pyelonephritis antibiotics: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
===Outpatient=== | ===Outpatient=== | ||
#[[Ciprofloxacin]] 500mg BID x10-14d OR | #[[Ciprofloxacin]] 500mg BID x10-14d OR | ||
#[[Cefpodoxime]] 200 mg BID x10-14d | #[[Cefpodoxime]] 200 mg BID x10-14d | ||
;Frequently, one is given IV before outpatient treatment | |||
*[[Ceftriaxone]] 1g IV x 1 AND/OR [[gentamycin]] 300mg IV x 1 | |||
===Inpatient Options=== | ===Inpatient Options=== | ||
*[[Ciprofloxacin]] 400mg IV q12hr OR | *[[Ciprofloxacin]] 400mg IV q12hr OR | ||
Revision as of 15:33, 22 February 2015
Outpatient
- Ciprofloxacin 500mg BID x10-14d OR
- Cefpodoxime 200 mg BID x10-14d
- Frequently, one is given IV before outpatient treatment
- Ceftriaxone 1g IV x 1 AND/OR gentamycin 300mg IV x 1
Inpatient Options
- Ciprofloxacin 400mg IV q12hr OR
- Ceftriaxone 1gm IV QD OR
- Cefotaxime 1-2gm IV q8hr OR
- Gentamicin 3mg/kg/day divided q8hr +/- ampicillin 1–2 gm q4hr OR
- Piperacillin/Tazobactam 3.375 gm IV q6hr OR
- Cefepime 2gm IV q8hr OR
- Imipenem 500mg IV q8hr